Public Companies
Believing you took ketamine during surgery has antidepressant effects: Stanford Medicine study
All participants in the placebo group reported a 50 per cent drop in depression symptoms after surgery
The post Believing you took ketamine during surgery…
Read more: PharmaTher Holdings enters collaboration to commercialize racemic ketamine Read more: Psycheceutical Bioscience develops non-psychoactive ketamine topical for PTSD and depressionThanks you Nina Bai @StanfordMed for the writeup of our study! out today in @NatMentHealth "Randomized trial of ketamine masked by surgical anesthesia in patients with depression"https://t.co/1AEUCtoGgg
— Boris D Heifets (@TheBorisLab) October 19, 2023
Researchers found results to be surprising
The researchers say those who reported the most significant improvements in their depression symptoms were more likely to believe they took ketamine, even when they didn’t.“It’s like looking at a Picasso painting,” said Schatzberg.“To put that into perspective, that brings them down to a category of mild depression from what had been debilitating levels of depression,” added Lii. Depression can worsen after surgery among many individuals, which made the scholars conclude that the surgeries and anesthesia were unlikely responsible for the participants’ improvements. The investigators said that the results may have been affected by the participants’ favourable view of ketamine and its recent popularity in helping with depression. “Maybe with a non-hallucinogenic psychedelic analogue you can get the same benefits without having to, you know, go to outer space,” Heifets added. Read more: EntheoTech Bioscience opens flagship ketamine clinic in Kelowna Read more: Awakn set to research ketamine for alcohol use disorder Ketamine has been gaining interest within the medical community in recent days for its potential to treat depression and an assortment of conditions. Ketamine therapy utilizing lozenges or intravenous administration has become a popular treatment option and business for different companies in Canada, many American states and abroad in recent years. Some, like Psycheceutical Bioscience Inc (OTC: BWVI), have even found ways to administer it without any psychoactive effects while retaining its therapeutic benefits through the use of a topical applied to the back of the neck. Others like the United Kingdom’s Awakn Life Sciences (NEO: AWKN) (OTCQB: AWKNF) have been studying the drug’s potential for the treatment of alcohol use disorder.
rowan@mugglehead.com
The post Believing you took ketamine during surgery has antidepressant effects: Stanford Medicine study appeared first on Mugglehead Magazine. ketamine psychiatry psychedelic psychoactive therapy depression antidepressant ptsd hallucinogenic otc pharmather awakn life sciences awakn research-
Psychedelics1 week ago
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024
-
Psychedelics1 week ago
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID
-
Law & Regulation1 week ago
Tryp Therapeutics merger with Exopharm approved by shareholders
-
Psilocybin1 week ago
Passover Perspectives: Psychedelics, Moses, and the Burning Bush
-
Psychedelics1 week ago
atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
-
Psychedelics1 week ago
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment
-
Psilocybin1 week ago
Psilocybin and Meditation: Unlocking the Potential for Enhancing Insightfulness
-
Psychedelics1 week ago
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment